Safety and efficacy of GLP-1/FGF21 dual agonist HEC88473 in MASLD and T2DM: a randomized, double-blind, placebo-controlled study.
Xiang L, Wang G, Zhuang Y, Luo L, Yan J, Zhang H, Li X, Xie C, He Q, Peng Y, Chen H, Li Q, Li X, Guo L, Lv G, Ding Y.
Xiang L, et al. Among authors: wang g.
J Hepatol. 2024 Dec 19:S0168-8278(24)02758-2. doi: 10.1016/j.jhep.2024.12.006. Online ahead of print.
J Hepatol. 2024.
PMID: 39709140